Name | Title | Contact Details |
---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
MTX Therapy Services is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sagamore Health Network, Inc. is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Medical Communication Systems is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Heritage of Edina Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.